Updated August /08/2020
|
|
- Hilary Pope
- 5 years ago
- Views:
Transcription
1 Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Directorate & Speciality Guideline for the management of adults with diabetes undergoing surgery and elective procedures Dr Simon Page Consultant, Diabetes & Endocrinology Acute Medicine Directorate Date of submission 14/08/2013 Updated August 2017 Date on which guideline must be reviewed (this should be one to three years) Explicit definition of patient group to which it applies (e.g. inclusion and exclusion criteria, diagnosis) 14/08/2020 This guideline includes: Adults with diabetes Short starvation (daycase) surgery Extended starvation (inpatient) surgery Version 6.0 Abstract Exclusion: Variable Rate Insulin Infusion (VRII) in critical care/high dependency; see separate guidelines from critical care Paediatrics This guideline describes the management of adult patients with diabetes undergoing day surgery on short starvation (less than 12 hours without a meal missing only one meal) and extended starvation regimens (more than 12 hours without a meal missing 2 meals or more) as inpatients for surgery. Page 1 of 21
2 Key Words Statement of the evidence base of the guideline has the guideline been peer reviewed by colleagues? Evidence base: (1-6) 1 NICE Guidance, Royal College Guideline, SIGN (please state which source). 2a meta analysis of randomised controlled trials 2b at least one randomised controlled trial 3a at least one well-designed controlled study without 3b randomisation at least one other type of well-designed quasiexperimental study 4 well designed non-experimental descriptive studies (ie comparative / correlation and case studies) 5 expert committee reports or opinions and / or clinical experiences of respected authorities 6 recommended best practise based on the clinical experience of the guideline developer Consultation Process Target audience Adults with diabetes; short starvation; extended starvation; day surgery; inpatient surgery. These guidelines were peer reviewed by senior medical and nursing staff in the Diabetes unit and ratified at the TC CGRM committee. The guidelines have also been reviewed by colleagues external to Diabetes including Pharmaceutical, Renal and Surgical and Anaesthetics colleagues. Evidence base: No. 5 The guidelines are adapted from recommendations contained within: NHS Diabetes (2011) Management of adults with diabetes undergoing surgery and elective procedures: improving standards, available at: areas_of_care/emergency_and_ inpatient/perioperative_management/ Barker et al., Association of Anaesthetists of Great Britain and Ireland Guidelines Anaesthesia 2015, p1-14 doi: /anae MHRA guidance on SGLT2 inhibitors available at: These guidelines were developed in conjunction with medical, nursing staff across the diabetes unit and pharmaceutical, renal, surgical and anaesthetics colleagues. NUH intranet, nursing, pharmacy & medical staff. This guideline has been registered with the trust. However, clinical guidelines are guidelines only. The interpretation and application of clinical guidelines will remain the responsibility of the individual clinician. If in doubt contact a senior colleague or expert. Caution is advised when using guidelines after the review date. Page 2 of 21
3 Contents Section Title Page number i) Front Sheet 1 ii) Front Sheet 2 iii) Contents 3 1 Diabetes and short starvation (Day case) surgery 4 assessment and management guidelines 2 Commonly used regimes 5 3 Day case (short starvation) non- medication 6 guidelines 4 Day case (short starvation) (1) 7 5 Day case (short starvation) (2) 8 6 Short starvation surgery admission guidance for 9 glucose assessment and management 7 Diabetes and extended starvation (inpatient) 10 surgery assessment and management guidelines 8 Inpatient surgery (extended starvation) non- 11 medication guidelines 9 Inpatient surgery (extended starvation) (1) Inpatient surgery (extended starvation) (2) Inpatient surgery (extended starvation) variable 14 rate intravenous infusion (VRII) 12 Transfer from VRII to usual diabetes medication 15 including 13 Hyperglycaemia and ketone testing pre- or postoperatively NUH Patient information leaflet for patients 17 undergoing surgery or procedures requiring a period of starvation 15 Sick Day rules for people with diabetes Patient discharge letter Primary Care Input to Service: surgical referral 20 diabetes data fact sheet 18 Pre-operative assessment for diabetes 21 Page 3 of 21
4 Diabetes and Short Starvation (Day case) Surgery Assessment and Management Guidelines Short starvation means less than 12 hours without a meal missing one meal Adult patient with diabetes referred for surgery Elective procedure? NO If surgery urgent Seek diabetes team advice on supplemental Consider VRIII regimen Will the patient be nil by mouth (NBM) for < 12 hr (miss no more than 1 meal)? HBA1c within the last 3 months? NO Check HBA1c < 69 mmol/mol (8.5%) NO Refer to GP or diabetes team for stabilisation YES YES YES YES Surgical admission plan Day before surgery admission? Day of surgery admission with extended stay Daycase? Book patient for admission on pre-op day Book patient for day of surgery admission Book patient for day surgery Page 4 of 21
5 Commonly Used Insulin Regimens Twice daily (bd) regimen Injections given pre-breakfast and pre-evening meal. Twice daily medium acting (Insulatard, Humulin I, Insuman basal). Pre-mixed human (Humulin M3, Insuman Comb 15, 25 or 50). Pre-mixed analogue (Novomix30, Humalog Mix 25 or Mix 50). Three times daily (tds) regimen Breakfast pre-mix (e.g. Novomix 30, Humalog Mix 25 or Mix 50). PLUS Evening meal short acting (e.g. Actrapid, Humulin S, Insuman Rapid, Novorapid, Insulin Fiasp, Humalog, Apidra,). PLUS Bedtime medium/long acting (e.g. Insulatard, Humulin I, Insuman Basal, Levemir, Lantus). OR Three times daily pre-mix (e.g. Novomix 30, Humalog Mix 25 or Mix 50). Basal bolus (qds) regimen Basal given once or twice daily Typically twice daily: Insulatard, Humulin I,Insuman Basal Typically once daily: Lantus, Levemir, Degludec morning or evening time PLUS Bolus with each meal, in doses proportionate to intended carbohydrate intake Human soluble : Actrapid, Humulin S, Insuman Rapid or Human rapid acting analogue : Novorapid, Insulin Fiasp, Humalog, Apidra Page 5 of 21
6 Day case (short starvation) non- medication guidelines Tablet Alpha glucosidase inhibitor Acarbose Meglitinide Repaglinide Netaglinide Biguanide Metformin Day before admission Take as normal Take as normal Take as normal Day of surgery CHECK BLOOD SUGAR ON ADMISSION Morning procedure Omit MORNING dose if NBM Omit MORNING dose if NBM Give LUNCHTIME dose if recovered and eating Afternoon procedure Give MORNING dose if eating Omit LUNCHTIME dose if NBM Give MORNING dose if eating Omit LUNCHTIME dose Sulphonylurea Gliclazide Glipizide Glibenclamide Take as normal Once daily Omit MORNING dose Twice daily Omit MORNING dose Once daily Omit MORNING dose Twice daily Omit MORNING. Give EVENING dose if eating OMIT evening dose if not eating Glitazone Pioglitazone Take as normal DPP-IV inhibitor Sitagliptin Saxagliptin Linagliptin Vildagliptin Take as normal SGLT2 inhibitor* Dapagliflozin Canagloflozin Empagliflozin Take as normal Omit on day of surgery Omit on day of surgery GLP-1 analogue Exenatide Liraglutide Lixisenatide Take as normal * MRHA guidance 2016: interrupt treatment with the SGLT2 inhibitor in patients who are hospitalised for major surgery or acute serious illnesses; treatment may be restarted once the patient s condition has stabilised Page 6 of 21
7 Day case (short starvation) (1) Insulin regimen Once daily evening Human NPH eg Insulatard; Humulin I Insuman Human analogue eg Levemir, Lantus, Degludec Once daily morning Human NPH e.g. Insulatard; Humulin I; Insuman. Human analogue e.g. Levemir; Lantus, Degludec. Twice daily Human NPH e.g. Insulatard; Humulin I; Insuman. Human pre-mixed e.g. Humulin M3; Insuman Comb 25;Insuman Comb 50. Human analogue premix e.g. Novomix 30; Humalog Mix 25 or Mix 50. Human analogue e.g. Levemir; Lantus. Twice daily free mix short & intermediate Short acting: e.g. animal neutral; Actrapid; Humulin S; Insuman Rapid; Novorapid; Humalog; Apidra Intermediate acting: e.g. animal NPH; Insulatard; Humulin I; Insuman Basal. Day before surgery No change No change No change No change Day of surgery CHECK BLOOD SUGAR ON ADMISSION Morning procedure Not applicable No dose change but administer usual dose after procedure Morning Usual MORNING dose after procedure Evening Usual dose Morning Usual morning doses after procedure Evening Usual dose Afternoon procedure No dose change Administer usual dose at usual time No dose change Morning Half of usual MORNING dose Evening Usual dose Morning Half of total morning dose as INTERMEDIATE acting Evening Usual dose Page 7 of 21
8 Day case (short starvation) (2) Insulin regimen Day before surgery Day of surgery CHECK BLOOD SUGAR ON ADMISSION Morning procedure Afternoon procedure Three times daily premix Humulin M3, Insuman Comb 15, 25 or 50, Novomix 30, Humalog Mix 25 or Mix 50 Basal bolus Continuous Subcutaneous Insulin Infusion (CSII) pump No change Morning Usual MORNING dose after procedure Lunchtime Usual LUNCHTIME dose if eating OMIT if not eating Evening Usual EVENING dose No change Basal unchanged Morning Omit MORNING bolus Lunchtime Usual LUNCHTIME bolus if eating OMIT if not eating. Evening Usual EVENING dose(s) No change Basal unchanged Omit bolus doses while on VRIII Seek Diabetes Team advice Morning Half usual MORNING dose Lunchtime Omit LUNCHTIME dose Evening Usual EVENING dose if eating OMIT if not eating Basal unchanged Morning Usual MORNING bolus if eating OMIT if not eating Lunchtime Omit LUNCHTIME bolus. Evening Usual EVENING dose(s) Basal unchanged Omit bolus doses while on VRIII Seek Diabetes Team advice Page 8 of 21
9 Short starvation Surgery Admission Guidance for Glucose Assessment and Management Refer to and/or tablet guidance tables for information on management of diabetes therapies Check capillary blood glucose ON ARRIVAL on ALL patients Fasting gluose < 4 mmol/l Fasting glucose 4-12 mmol/l Fasting glucose > 12 mmol/l Fasting glucose > 25 mmol/l Give 200ml of 10% glucose iv over 10 min (antecubital fossa vein) Recheck blood glucose in 15 mins Ketone check required Urine ketones (Ketostix) Plasma ketones 1.5 mmol/l Urine ketones ++ Cancel Procedure Diabetes team referral Blood ketones (meter if available) Plasma ketones > 1.5 mmol/l Urine ketones > ++ Safe to Proceed with Surgery Unsafe to Proceed with Surgery Recovery: Monitor capillary glucose at least hourly CANCEL PROCEDURE Diabetes team referral Discharge: Provide information on sick day rules and written advice on monitoring their diabetes Advise ALL patients to continue their usual diabetic treatment with their evening meal. If hypoglycaemia (< 4 mmol/l) give: 200 ml of 10% glucose iv (antecubital fossa vein) Recheck glucose after 15 MINUTES If hyperglycaemia (> 12 mmol/l) and: T1D give sc rapid acting analogue based on 1 Unit of lowering blood glucose by 3 mmol/l T2D 0.1Unit/kg sc rapid acting analogue Recheck glucose after 1 HOUR Page 9 of 21
10 Diabetes and extended starvation (inpatient) surgery assessment and management guidelines Extended starvation means more than 12 hours without a meal missing 2 meals or more Principles 1. Not usually necessary to admit patients with diabetes the day before surgery 2. Prioritise patients with diabetes on elective surgical lists 1st on morning list 1st on afternoon list 3. Monitor capillary blood glucose hourly during surgery 4. Suggested operative glucose target range 6-10 mmol/l good 4-12 mmol/l acceptable 5. In patients on basal continue this during the operative and postoperative period Page 10 of 21
11 Inpatient surgery (extended starvation) non- medication guidelines Tablet Alpha glucosidase inhibitor Acarbose Meglitinide Repaglinide Netaglinide Biguanide Metformin Day before admission Day of surgery CHECK BLOOD SUGAR ON ADMISSION Morning procedure Afternoon procedure Omit MORNING dose if NBM Omit MORNING dose if NBM Give MORNING dose if eating, otherwise omit Omit LUNCHTIME dose if NBM Give MORNING dose if eating Omit LUNCHTIME dose Sulphonylurea Gliclazide Glipizide Glibenclamide Once daily Omit MORNING dose Twice daily Omit MORNING dose Once daily Omit MORNING dose Twice daily Omit MORNING dose. Give EVENING dose if eating otherwise omit Glitazone Pioglitazone DPP-IV inhibitor Sitagliptin Saxagliptin Linagliptin Vildagliptin SGLT2 inhibitor* Dapagliflozin Canagloflozin Empagliflozin Omit on day of surgery Omit on day of surgery Omit on day of surgery Omit on day of surgery GLP-1 analogue Exenatide Liraglutide Lixisenatide Omit on day of surgery Omit on day of surgery * MRHA guidance 2016: interrupt treatment with the SGLT2 inhibitor in patients who are hospitalised for major surgery or acute serious illnesses; treatment may be restarted once the patient s condition has stabilised Page 11 of 21
12 Inpatient surgery (extended starvation) (1) Insulin regimen Once daily evening Human NPH eg Insulatard; Humulin I Insuman Day before admission No change Day of surgery CHECK BLOOD SUGAR ON ADMISSION Morning Afternoon procedure procedure Not applicable Evening dose Usual dose if using Lantus, Levemir or Degludec with VRIII. Human analogue eg Levemir, Lantus, Degludec Once daily morning Human NPH e.g. Insulatard; Humulin I; Insuman. No change Morning dose Usual dose if using Lantus, Levemir or Degludec Omit if NPH and VRIII is use Not applicable Human analogue e.g. Levemir; Lantus, Degludec. Twice daily Human NPH e.g. Insulatard; Humulin I; Insuman. Human pre-mixed e.g. Humulin M3; Insuman Comb 25;Insuman Comb 50. No change Omit if NPH and VRIII in use Morning dose Omit Evening dose Usual dose if eating Omit if using VRIII Morning dose Halve usual dose if eating Evening dose Omit if using VRIII Human analogue premix e.g. Novomix 30; Humalog Mix 25 or Mix 50. Human analogue e.g. Levemir; Lantus. Twice daily free mix short & intermediate Short acting: e.g. animal neutral; Actrapid; Humulin S; Insuman Rapid; Novorapid; Humalog; Apidra Intermediate acting: e.g. animal NPH; Insulatard; Humulin I; Insuman Basal. No change Morning dose Omit Evening dose Usual dose if eating Omit if using VRIII Morning dose Half of total dose as INTERMEDIATE acting Evening dose Omit if using VRIII Page 12 of 21
13 Inpatient surgery (extended starvation) (2) Insulin regimen Three times daily premix Humulin M3, Insuman Comb 15, 25 or 50, Novomix 30, Humalog Mix 25 or Mix 50 Day before admission No change Day of surgery CHECK BLOOD SUGAR ON ADMISSION Morning procedure Afternoon procedure Morning dose Omit MORNING dose Lunchtime dose Usual LUNCHTIME dose if eating Omit if using VRIII Evening dose Usual EVENING dose if eating Omit if using VRIII Morning dose Halve usual MORNING dose Lunchtime dose Omit LUNCHTIME dose Evening dose Usual EVENING dose if eating OMIT if using VRIII Basal bolus No change Basal unchanged Basal unchanged Omit prandial while on VRIII Usual MORNING prandial if having breakfast Continuous Subcutaneous Insulin Infusion (CSII) pump No change Basal unchanged Omit bolus doses while on VRIII Omit prandial if using VRIII Basal unchanged Omit bolus doses while on VRIII Seek Diabetes Team advice Seek Diabetes Team advice VRIII = variable rate intravenous infusion Page 13 of 21
14 Inpatient surgery (extended starvation) variable rate intravenous infusion (VRIII) Mandatory for patients with Type 1 diabetes Strongly recommended for patients with tablet or GLP-1 injectable controlled T2D Continue basal : Humulin I, Insulatard, Insuman Basal, Lantus, Levemir, Insulin Degludec ml 0.9% saline plus 50 units of SOLUBLE in syringe pump Capillary blood glucose (mmol/l) Insulin infusion rate (Units per hr) < (0.0 if basal continued) > 20 5 See NUH prescription chart for further advice if required. Fluids Use 5% Dextrose with 20mmol KCl** in 500ml at 100ml/hr In patients needing fluid restrictions use 10% Dextrose with 20 mmol KCl** at 50ml/hr Administration via volumetric infusion pump. Insulin and fluids MUST be administered together via a single cannula Monitoring Hourly capillary blood glucose monitoring during VRIII Daily U+E/creatinine ** Caution in patients with Chronic Kidney Disease Page 14 of 21
15 Transfer from VRIII to usual Post-operative patient on VRIII NO Eating and drinking? Pre-op oral agents Pre-op (+/- oral agent(s) Pre-op GLP-1 (+/- oral agent(s) Re-start usual dose(s)/usual times May need temporary reduced dose of sulphonylurea if oral intake reduced Re-start metformin only if egfr>50 ml/min Re-start usual dose(s)/usual times May need temporary reduced dose of sulphonylurea if oral intake reduced Re-start metformin only if egfr>50 ml/min Od Bd mix Basal bolus Insulin Pump Re-start usual dose/usual time Continue VRIII until 2 hrs AFTER usual given Re-start before breakfast or before evening meal at usual dose Continue VRIII until 1 hr AFTER usual given Re-start prandial at next meal (assuming basal was continued) If basal stopped re-start at usual time and continue VRII for 2 hrs AFTER basal dose Basal rate should have been continued Usual bolus dose with next meal Seek Diabetes Team advice Page 15 of 21
16 Hyperglycaemia and ketone testing pre- or post-operatively In a pre or post-operative patient with hyperglycaemia (glucose >12 mmol/l) measurement of plasma ketones is recommended. Capillary glucose > 12 mmol/l Measure blood ketones using appropriate meter and test strip < 1 mmol/l 1-3 mmol/l 3-6 mmol/l > 6 mmol/l NO VRIII in progress? YES Normal Review diabetes treatment regimen T1D give sc rapid acting analogue based on 1 Unit of lowering blood glucose by 3 mmol/l T2D 0.1Unit/kg sc rapid acting analogue Recheck glucose after 1 HOUR and repeat as needed. Diabetes team review advised Check lines/infusion pump Increase infusion rate Diabetes team review advised Urgent Request for U+E, glucose, venous blood gas (ph and bicarbonate) Urgent diabetes team opinion or Diabetes Registrar (or on call medical registrar if out of hours) Page 16 of 21
17 Patient information leaflet for patients undergoing surgery or procedures requiring a period of starvation Treatment with tablets or injections of, Exenatide or Liraglutide Please follow the instructions in the enclosed table which provide information on what you should do with your tablet or injection treatment prior to your planned surgery If your operation is in the morning Do not eat any food after midnight Drink clear fluids such as water, black tea of coffee or sugar-free squash if required up until 05.00am If your operation is in the afternoon Eat breakfast before 06.00am and take no food after this time Drink clear fluids such as water, black tea of coffee or sugar-free squash if required up until 10.00am When you travel to and from the hospital for your operation please carry some glucose tablets, or a sugary drink (such as a 200ml carton of orange juice) with you What if I have a hypo? If you have symptoms of a low blood sugar such as sweating, shaking, dizziness, poor concentration or blurred vision please test your blood sugar if able to do so. If it is less than 4 mmol/l take 4 glucose tablets or a 200ml carton of orange juice, or ½ can of a sugary drink such as coca cola. Re-check your blood sugar mins after treating the hypo. Inform the staff at the hospital if you have had to do this. Remember to bring with you to the hospital Glucose tablets, a carton of orange juice or a sugary drink Your blood glucose monitoring equipment if you usually monitor your sugars at home) The tablets or injections you usually take for your diabetes After your operation You will be offered food and drink when you feel able to eat. You should resume your usual treatments for diabetes once you are eating and drinking Be aware that your sugar levels may be higher than usual for the first day or two after surgery If you feel unwell after returning home please refer to the SICK DAY RULES information sheet Contact your GP or diabetes care provider if things don t improve. Page 17 of 21
18 Sick Day Rules for People with Diabetes What to do if you are unwell NEVER stop taking your or tablet illness usually increases your body s need for TEST your blood sugars every 2 hours, day and night TEST your urine for KETONES every time you go to the toilet or test your blood ketones every 2 hours if you have a suitable meter DRINK at least a cup (100 ml) of water/sugar free fluid every hour aim to drink about 5 pints (2.5 litres) per 24 hours REST and avoid strenuous exercise since this may increase your blood sugars during exercise EAT normally if you can. If you have a smaller appetite than usual replace a meal with: 400ml milk or 200ml carton fruit juice or 200 ml non-diet fizzy drink or 1 scoop ice cream When should I call for help? CONTINUOUS diarrhoea and/or vomiting and/or a high fever UNABLE to keep food down for 4 hours or more HIGH blood glucose levels (over 12 mmol/l) with symptoms of illness you may need more KETONES at 2++ or 3++ in your urine or more than 1.5 mmol/l in your blood you may need more If you are concerned please CONTACT the person or the clinical service that normally helps you to look after your diabetes OUTSIDE NORMAL WORKING HOURS Consult the local out of hours service or go to your local hospital Emergency Department Page 18 of 21
19 Patient Discharge Letter Advice for patients with diabetes who are discharged following a surgical procedure 1. Continue to take your or tablet medication as usual when you get home. 2. Check your blood sugars if you have the equipment to do so 4 times per day, or more frequently if you don t feel well, or are feeling or being sick. 3. Your blood sugar may be higher than usual; this is not a concern provided you are feeling well. 4. If you are feeling unwell, especially if you are being sick and unable to take food or medication please see the accompanying Sick Day Rules information sheet for further advice. Page 19 of 21
20 Primary care input to service Surgical referral diabetes data factsheet NHS Diabetes has recently produced recommendations on the management of diabetes in patients undergoing surgery The recommendations emphasise the importance of optimising diabetes management prior to surgery, promoting day surgery where possible, avoiding the use of unnecessary infusions and promoting an early resumption of a patient s usual diet and diabetes management. Please include the following information in ANY referral of a patient with diabetes for possible surgery: Up to date current diabetes care Duration and Type of diabetes Main site of delivery of care Primary or Secondary care Co-morbidities Treatment o For diabetes oral agents/non- injectables/ regimen o For other co-morbidities Specific complications of diabetes At risk foot Renal impairment Cardiac disease Hypertension Most recent values for BMI BP HBA1c egfr Page 20 of 21
21 Pre-operative Assessment (Diabetes) Please circle or add data as appropriate Diabetes type Type 1 Type 2 Other: Details Diabetes duration Usual place of care... yrs Primary care GP Secondary care Consultant Treatment oral agent (name) Metformin SU Pioglitazone Gliptin SGLT2 Acarbose Dose and frequency Treatment - injection GLP-1 name Insulin name Dose/frequency Complications (details if available) (free text) At risk foot Renal impairment Cardiac disease Latest data BMI. Kg/m 2 Date././. BP../.. mmhg Date././. Latest lab data egfr ml/mim Date././. HBA1c mmol/mol Date././. Page 21 of 21
Information for Patients
Information for Patients Guidance for Diabetic Persons having an OGD or Bronchoscopy This guidance is provided to assist with your preparation for your endoscopic procedure. If you feel unclear about how
More informationPeri-operative management of the surgical patient with diabetes GL059
DT Peri-operative management of the surgical patient with diabetes GL059 Approval Approval Group Job Title, Chair of Committee Date Anaesthetics Clinical Governance Chair Anaesthetic governance Nov 2016
More informationFasted and Consented but Blood Glucose 18mmol/L or How to Manage Diabetes in the Peri-Operative Period
Fasted and Consented but Blood Glucose 18mmol/L or How to Manage Diabetes in the Peri-Operative Period Dr Ketan Dhatariya MBBS MSc MD MS FRCP Consultant in Diabetes and Endocrinology Norfolk and Norwich
More informationPERIOPERATIVE DIABETES GUIDELINE
PERIOPERATIVE DIABETES GUIDELINE This Guideline does not replace the need for the application of clinical judgment in respect to each individual patient. Background Diabetes mellitus is estimated to affect
More informationTitle Peri-operative Guidelines for the Management of Patients with Diabetes. Author s job title Diabetes Specialist Nurse Department.
Patients with Document Control Title Peri-operative Guidelines for the Management of Patients with Author Directorate Medicine Version Date Issued 0.1 Jan 2011 Status Draft Initial version Author s job
More informationClinical Guidelines. Management of adult patients with diabetes undergoing endoscopic procedures
Clinical Guidelines Management of adult patients with diabetes undergoing endoscopic s Document Detail Document type Clinical Guideline Management of adult Patients with diabetes Undergoing Document name
More informationPeri-Operative Guidelines for Management of Diabetes Patients
Peri-Operative Guidelines for Management of Diabetes Patients Target blood glucose 6-10 mmol/l for all patients Acceptable blood glucose 4-11 mmol/l for all patients Definitions Non-Insulin Glucose Lowering
More informationHow they work and when to take them. Diabetes Medications
How they work and when to take them Diabetes Medications BIGUANIDES Metformin Actions Slows down the release of glucose from the liver. Helps the bodies cells become more sensitive to insulin. Pros Weight
More informationStaff at the Nottingham Children s Hospital. Guidelines process.
Diabetes and Surgery Title of Guideline Contact Name and Job Title (author) Guideline for the management of children and young people with diabetes aged 18 or under requiring surgery Dr Priyha Santhanam,
More informationManagement of Adults with Diabetes Undergoing Surgery and Elective Procedures Guidelines. Diabetes Inpatient Steering Group June 2016
Management of Adults with Diabetes Undergoing Surgery and Elective Procedures Guidelines Diabetes Inpatient Steering Group June 2016 1. Introduction 1.1 The aim of the guideline is to improve standards
More informationNorthumbria Healthcare NHS Foundation Trust. Sick Day Rules for People with Diabetes. Issued by the Diabetes Service
Northumbria Healthcare NHS Foundation Trust Sick Day Rules for People with Diabetes Issued by the Diabetes Service www.northumbria.nhs.uk Background: How illness may affect your diabetes 3 What to do for
More informationThe principles of insulin adjustment guidance
The principles of insulin adjustment guidance Tips for insulin titration Blood glucose (BG) monitoring is needed to help identify the efficacy of treatment in diabetes. Monitor blood glucose according
More informationGuideline for Children with Type 1 or Type 2 Diabetes on Insulin Requiring Surgery or Sedation
CHILDREN S SERVICES Guideline for Children with Type 1 or Type 2 Diabetes on Insulin Requiring Surgery or Sedation Background Surgery places stress on the body and will alter glucose control and insulin
More informationOxford Kidney Unit. Preparing for your operation: information for people with chronic kidney disease
Oxford Kidney Unit Preparing for your operation: information for people with chronic kidney disease page 2 You have been given this booklet to help you prepare for a surgical procedure under general anaesthetic.
More informationGlucose Control drug treatments
Glucose Control drug treatments It should be noted that glitazones are under suspicion of precipitating acute cardiac events and current recommendations contraindicate the use of glitazones in patients
More informationManaging diabetes if you are having a colonoscopy
Managing diabetes if you are having a colonoscopy Diabetes and Endocrinology Patient Information Leaflet Introduction This leaflet provides advice and instructions to people with diabetes who are going
More informationDept of Diabetes Main Desk
Dept of Diabetes Main Desk 01202 448060 Glucose management in Type 2 Diabetes in Adults The natural history of type 2 diabetes is for HbA1c to deteriorate with time. A stepwise approach to treatment is
More informationSt Helens & Knowsley Teaching Hospitals Adult Inpatient Diabetes Management Guidelines v24
St Helens & Knowsley Hospitals, 2014-16 Adult Inpatient Diabetes Management Guidelines St Helens & Knowsley Teaching Hospitals Adult Inpatient Diabetes Management Guidelines 2014-2016 v24 Title Adult Inpatient
More informationInpatient Diabetes 20/01/2015. What should I do? Hyperglycaemia why does it matter? Why are the BSLs unstable? BSL parameters
Hyperglycaemia why does it matter? Inpatient Diabetes Angela Sheu Endocrine Registrar St George Hospital Hyperglycaemia at admission is a predictor of mortality May be part of stress response (eg post
More informationDiabetes, Ketone testing in Type 1 Diabetes
CLINICAL GUIDELINE Diabetes, Ketone testing in Type 1 Diabetes A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments. Clinical judgement should be exercised
More informationDIABETES Self Directed Test (12 Hours) Name: Ward/Practice Area: Mailing Address:
1 DIABETES Self Directed Test (12 Hours) Name: Ward/Practice Area: Mailing Address: 2 Learning Outcomes All nurses, regardless of practice setting, are required to work collaboratively with the person
More informationManaging Hyperglycaemia in Acute (Adult) Inpatients Requiring Enteral Feeding Guidelines
Document Control Title Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Author Author s job title Specialist Nurse Consultant Physician Department Directorate Unscheduled Care Version Date
More informationManagement of adults with diabetes undergoing surgery and elective procedures: improving standards
Surgical outpatients Hospital admission Theatre and recovery Discharge Primary care referral Pre-operative assessment Post-operative care Management of adults with diabetes undergoing surgery and elective
More informationThere have been important changes in diabetes care which may not be covered in undergraduate textbooks.
Diabetes Clinical update There have been important changes in diabetes care which may not be covered in undergraduate textbooks. Changes in the diagnosis of diabetes a) HbA1C Since 2011, World Health Organisation
More informationGuidelines for the care of Children with Diabetes Mellitus undergoing Surgery
Guidelines for the care of Children with Diabetes Mellitus undergoing Surgery Background Surgery places physical and emotional stress on the body. This, alongside new surroundings, parental anxiety and
More informationGuideline on Sick day rules for children and young people with diabetes on insulin
Guideline on Sick day rules for children and young people with diabetes on insulin META DATA Title: Guidelines on Sick day rules for children and young people with Diabetes taking insulin Version: 1.0
More informationEnd of Life Diabetes Care
End of Life Diabetes Care Commissioned by Diabetes UK Supplementary Documents and Flowcharts Endorsed By: Diabetes Phases of End of Life and Medications A - Blue: All From Diagnosis Stable With Year Plus
More informationInformation for all patients taking insulin who are admitted to hospital on day of surgery
Information for all patients taking insulin who are admitted to hospital on day of surgery Exceptional healthcare, personally delivered Introduction Many patients are now admitted to hospital on the day
More informationPre admission & surgery Pre-admission Nurses Association SIG Catherine Prochilo Credentialled Diabetes Nurse Educator Sat 23 March 2013
Pre admission & surgery Pre-admission Nurses Association SIG Catherine Prochilo Credentialled Diabetes Nurse Educator Sat 23 March 2013 www.diabetesvic.org.au Plan/ overview Issue/ presenting problems
More informationInitiating Injectables in Type 2 Diabetes. Tara Kadis Team Leader Diabetes Nurse Specialist York Teaching Hospital
Initiating Injectables in Type 2 Diabetes Tara Kadis Team Leader Diabetes Nurse Specialist York Teaching Hospital Increasing levels in delivery of diabetes care Complex Care support 3 3.1 People with diabetes
More informationDiabetes, Type 2 Management
CLINICAL GUIDELINE Diabetes, Type 2 Management A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments. Clinical judgement should be exercised on the applicability
More informationGuideline for the perioperative management of diabetes for Adult patients undergoing surgery
Guideline for the perioperative management of diabetes for Adult patients undergoing surgery This guidance does not override the individual responsibility of health professionals to make appropriate decision
More informationInjectable Therapies in Diabetes
Injectable Therapies in Diabetes Diabetes Specialist Nurse Joyce Robson Learning Outcomes Think about the place of injectible therapies in diabetes Insulin therapy GLP1 antagonists Consider commonly used
More informationWhat the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin
Diabetes s Oral s - Pills These are some of the pills that are currently available in Canada to treat diabetes. Each medication has benefits and side effects you should be aware of. Your diabetes team
More information667FM.5.1 MANAGEMENT OF TYPE 2 DIABETES: BLOOD-GLUCOSE-LOWERING THERAPY
667FM.5.1 MANAGEMENT OF TYPE 2 DIABETES: BLOOD-GLUCOSE-LOWERING THERAPY Contents Introduction... 1 Patient Education for People with Type 2 Diabetes... 2 Dietary Advice for People with Type 2 Diabetes...
More informationDiabetes Emergency Caesarean section or other unplanned surgery (GL822)
Diabetes Emergency Caesarean section or other unplanned surgery (GL822) i.e. insulin dependent diabetic having unplanned surgery e.g. a diabetic woman with pre-labour SROM prior to elective Caesarean section.
More informationHow can we improve outcomes in Type 2 diabetes?
How can we improve outcomes in Type 2 diabetes? Earlier diagnosis Better patient education Stress central role of lifestyle management Identify and treat all risk factors Use rational pharmacological therapy
More informationTREATMENTS FOR TYPE 2 DIABETES. Susan Henry Diabetes Specialist Nurse
TREATMENTS FOR TYPE 2 DIABETES Susan Henry Diabetes Specialist Nurse How can we improve outcomes in Type 2 diabetes? Earlier diagnosis Better patient education Stress central role of lifestyle management
More informationInjectable Therapies in Diabetes
Injectable Therapies in Diabetes Diabetes Specialist Nurse Linda Burns Learning Outcomes Understand the place of injectible therapies in diabetes Understand when patients may require insulin therapy Consider
More informationSTEP 3: Add or Substitute with one of
Prescribing of Hypoglycaemic Agents for Adult Patients with Type 2 Diabetes: Sunderland Refer to DESMOND Structured Education classes to promote Increased Physical Activity, Weight Loss and Calories Reduction
More informationClinical Guideline for the management of paediatric patients with Diabetes Type 1 & 2 requiring Surgery or General Anaesthetic. V4
Clinical Guideline for the management of paediatric patients with Diabetes Type 1 & 2 requiring Surgery or General Anaesthetic. V4 Page 1 of 27 Abbreviation Meaning PDSN DKA BG SC IV RCHT HDU PEWS Paediatric
More informationExecutive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules)
Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) SETTING FOR STAFF PATIENTS Medical and nursing staff Children and young
More informationEast of England Children & Young People s (CYP) Diabetes Network
East of England Children & Young People s (CYP) Diabetes Network Management of Children and Young people with Diabetes (Age >6months-18th birthday) Requiring Surgery and Other Procedures Communication
More informationDrugs used in Diabetes. Dr Andrew Smith
Drugs used in Diabetes Dr Andrew Smith Plan Introduction Insulin Sensitising Drugs: Metformin Glitazones Insulin Secretagogues: Sulphonylureas Meglitinides Others: Acarbose Incretins Amylin Analogues Damaglifozin
More informationInjectable Therapies in Diabetes
Injectable Therapies in Diabetes Diabetes Specialist Nurse Joyce Robson Learning Outcomes Think about the place of injectible therapies in diabetes Think about when / why patients require insulin therapy
More informationPlease inform the Diabetes Nurse Specialist that this patient has been admitted within 24hrs of admission.
Adult Diabetic Ketoacidosis Care Bundle (V1. Issued October 2014 Review October 2015) Improving patient care This pack includes: DKA Management Guideline Name: (Patient Addressograph) DOB: Hospital No:
More informationLynda Astbury Lead Diabetes Specialist Nurse
Lynda Astbury Lead Diabetes Specialist Nurse WARNING SIGNS AND SYMPTOMS Is patient Feeling unwell? Blood glucose level above 13mmol/L Or higher than the patients day to day readings (even if not eating)
More informationAdjusting Your Diabetes Medicine and Diet for a Test or Procedure
health information Adjusting Your Diabetes Medicine and Diet for a Test or Procedure The guidelines below will help you adjust your diabetes medicine and diet as you get ready for your procedure or lab
More informationEndoscopy or colonoscopy guidelines
Endoscopy or colonoscopy guidelines for patients with diabetes The development and audit of local pilot guidelines for patients with diabetes undergoing an endoscopy or colonoscopy as an out-patient D
More informationShort-acting insulins. Biphasic insulins. Intermediate- and long-acting insulins
Recommended Insulin Products This guideline states the Gloucestershire Joint Formulary recommended, first choice insulin products. The intention is to support the choice of treatment for new patients,
More informationManagement of Women with Type I Diabetes or Insulin Treated Type II Diabetes
Management of Women with Type I Diabetes or Insulin Treated Type II Diabetes Author: Women & Child Health Specialty: Labour Ward Forum Date Approved: March 2017 Approved by: W&CH Clinical Governance Committee
More informationYOU HAVE DIABETES. Angie O Connor Community Diabetes Nurse Specialist 25th September 2013
YOU HAVE DIABETES Angie O Connor Community Diabetes Nurse Specialist 25th September 2013 Predicated 2015 figures are already met 1 in 20 have diabetes:1in8 over 60years old Definite Diagnosis is key Early
More informationPATIENT INFORMATION LEAFLET MEDICINE TO TREAT: DIABETES
PATIENT INFORMATION LEAFLET MEDICINE TO TREAT: DIABETES α-glucosidase inhibitor Biguanide DPP-IV inhibitor Meglitinide Sulphonylurea SGLT-2 Inhibitors 1. What are these medicines used for? These medicines
More informationTHIS IS A PATIENT HAND HELD DOCUMENT CARE PATHWAY FOR MANAGEMENT OF INITIATION OF INSULIN
Worcestershire Trusts Please attach patient sticker here or record: GP Name: Consultant:. Ward: THIS IS A PATIENT HAND HELD DOCUMENT CARE PATHWAY FOR MANAGEMENT OF INITIATION OF INSULIN This Care Pathway
More informationThis guideline was adapted in collaboration with Dr Georgina Walker and the Palliative Care Team at Rowcroft Hospice. With thanks.
Title: Directorate: Responsible for review: Ratified by: DIABETES, MANAGEMENT OF IN PALLIATIVE CARE PATIENTS General Medicine Diabetes Specialist Nurse Service Delivery Unit Clinical Director of Pharmacy
More informationArrange 3 Monthly Review Re-enforce LIFESTYLE advice and check DRUG COMPLIANCE at each visit Target HbA1c < 53mmol/mol
Prescribing of Hypoglycaemic Agents for Adult Patients with Type 2 Diabetes: Sunderland Refer to DESMOND Structured Education classes to promote Increased Physical Activity, Weight Loss and Calories Reduction
More informationTYPE 1 DIABETES MELLITIS CARE OF WOMEN IN BIRTHING SUITE
TYPE 1 DIABETES MELLITIS CARE OF WOMEN IN BIRTHING SUITE DEFINITION Type 1 Diabetes: described as a total lack of insulin produced by the pancreas for the requirements of the tissues. If left untreated,
More informationTYPE 1 DIABETES on 4 or more injections per day. Advice from the Cedar Centre. x 4 or more. Patient information leaflet
TYPE 1 DIABETES on 4 or more injections per day Advice from the Cedar Centre x 4 or more Patient information leaflet How do I look after myself if I am unwell and have DIABETES? Anyone can get flu or a
More informationManaging Special Circumstances Key Points
Managing Special Circumstances Key Points Hypoglycaemia Dr Arla Ogilvie Diabetes Consultant (Watford) Sick Day Rules Janet Guest Community DSN (Hertford) Preparing for Colonoscopy Carolyn Jones In-Patient
More informationPharmacological Glycaemic Control in Type 2 Diabetes
Pharmacological Glycaemic Control in Type 2 Diabetes Aim(s) and Objective(s) This guideline aims to offer advice on the pharmacological management for those who require measures beyond diet and exercise
More informationMr Gavin Hendry. Mr Rab Burtun. Prof Jim Mann. Diabetes Nurse Facilitator, Auckland. Dunedin. Human Nutrition & Medicine University of Otago, Dunedin
Mr Rab Burtun Diabetes Nurse Facilitator, Auckland Mr Gavin Hendry Dunedin Prof Jim Mann Human Nutrition & Medicine University of Otago, Dunedin Insulin Master Class Presented by: Prof Jim Mann Gavin Hendry
More informationDIABETES INDICATIONS FOR INSULIN
DIABETES INDICATIONS FOR INSULIN 1 Introduce the likely need for insulin in the future early on as part of patient education Emphasise that it is the pancreas that fails not the patient Assess if greater
More informationInsulin Therapies: An Educational Toolkit
University Hospitals of Leicester, Department of Diabetes and Leicester Diabetes Centre: Insulin Therapies: An Educational Toolkit This document is designed for use by those trained and competent in insulin
More informationDiabetes Update: Keeping patients safe. Victoria Ruszala MFRPSII North Bristol NHS Trust
Diabetes Update: Keeping patients safe Victoria Ruszala MFRPSII North Bristol NHS Trust Declaration of Interests I have received funding from the following companies for providing education sessions, attending
More informationSociety for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery
Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Girish P. Joshi, MB BS, MD, FFARCSI Anesthesia & Analgesia
More informationMaking Foot Surgery Safer for Patients with Diabetes
Making Foot Surgery Safer for Patients with Diabetes Building a New Trust Pathway Patient Safety Briefing The Newcastle Peri-operative Diabetes Pathway Launched 9 May 2016 Aims to join up peri-operative
More informationGuidelines for the Management of Diabetic Ketoacidosis (DKA) in Adults Inpatient Diabetes Steering Group
Guidelines for the Management of Diabetic Ketoacidosis (DKA) in Adults Inpatient Diabetes Steering Group 1. Introduction 1.1 This document sets out the University Hospitals of Leicester (UHL) guidelines
More informationSick day rules. associated with insulin dependent diabetes. Information for children and young people. Women and Children Paediatrics
Sick day rules associated with insulin dependent diabetes Information for children and young people Women and Children Paediatrics This information leaflet is for children and young people. If a parent
More informationMellitus undergoing Surgery
Clinical Guideline Care of children Children and young under people with 18 diabetes years mellitus with Diabetes Mellitus undergoing Surgery SETTING FOR STAFF PATIENTS Insert hospital name Medical and
More informationManagement of adults with diabetes undergoing surgery and elective procedures: Improving standards
Management of adults with diabetes undergoing surgery and elective procedures: Improving standards Revised September 2015 Changes in the second edition of the peri-operative document Preoperative pathway
More informationDiabetes Labour guideline (GL820)
Diabetes Labour guideline (GL820) Approval Approval Group Job Title, Chair of Committee Date Maternity & Childrens Services Mr Mark Selinger, Consultant 6 th June 2014 Clinical Governance Committee Obstetrician
More informationLeicestershire Diabetes Guidelines: Insulin Therapy
Endorsed by Leicestershire Medicines Strategy Group Leicestershire Diabetes Guidelines: Insulin Therapy These guidelines are designed for use by those trained and competent in insulin initiation and management
More informationWhat do you need to know before you go home?
What do you need to know before you go home? What is Insulin Types of Insulin Injection Sites How to Inject Insulin Correctly Low Blood Sugar and Treatment Sick Day Management After leaving the Hospital:
More informationEast of England Paediatric Diabetes Network
East of England Paediatric Diabetes Network Management of Children and Adolescents with Diabetes Requiring Surgery and Other Procedures Early & Effective Communication Surgeon/physician communicates with
More informationManagement of adults with diabetes undergoing surgery and elective procedures: Improving standards Summary
Management of adults with diabetes undergoing surgery and elective procedures: Improving standards Summary Revised March 2016 Lead authorship Dr Ketan Dhatariya Consultant in Diabetes, Norfolk and Norwich
More informationContinuous Subcutaneous Insulin Infusion (CSII) pump therapy
Page 1 of 14 Continuous Subcutaneous Insulin Infusion (CSII) pump therapy Introduction This booklet has been compiled by the Insulin Pump Therapy Team to standardise the information given to patients on
More informationGuidelines to assist General Practitioners in the Management of Type 2 Diabetes. April 2010
Guidelines to assist General Practitioners in the Management of Type 2 Diabetes April 2010 Foreword The guidelines were devised by the Diabetes Day Centre in Beaumont Hospital in consultation with a number
More informationGastroscopy - Oesophago-gastro duodenoscopy (OGD)
James Paget University Hospitals NHS Foundation Trust Gastroscopy - Oesophago-gastro duodenoscopy (OGD) The procedure explained. Your appointment details, information and consent form. Patient Information
More informationMANAGEMENT OF TYPE 2 DIABETES
MANAGEMENT OF TYPE 2 DIABETES 3 Month trial of lifestyle changes. Refer to DESMOND structured education programme. Set glycaemic target HbA1c < 7.0% (53mmol/mol) or individualised If HbA1c > 53mmol/mol
More informationObjectives. Why is blood glucose important? Hypoglycaemia. Hyperglycaemia. Acute Diabetes Emergencies (DKA,HONK)
Acute Diabetes Emergencies Ross Buchan, DSN North Glasgow June 2017 Objectives Why is blood glucose important? Hypoglycaemia Hyperglycaemia Acute Diabetes Emergencies (DKA,HONK) Importance of Blood Glucose
More informationEssential advice for people with diabetes from Accu-Chek. The inside story on diabetes
Essential advice for people with diabetes from Accu-Chek The inside story on diabetes What is diabetes? Glucose is a form of sugar that is found in food you eat. It is a vital energy source for your body
More informationInpatient Diabetes Care
Inpatient Diabetes Care Data from the National Diabetes Inpatient Audit suggest that the number of hospital inpatients with diabetes ranges from ~10% to over 30%. This does not mean that up to 1 in 3 inpatients
More informationTYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS
TYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS The aim of the Diabetes level 2 service is to provide a high quality service for safe initiation and optimization of injectable therapy within GP networks.
More informationManaging Diabetes when you are having a colonoscopy
Managing Diabetes when you are having a colonoscopy Disclaimer This is general information developed by The Ottawa Hospital. It is not intended to replace the advice of a qualified health-care provider.
More informationMANAGEMENT OF PREGNANT WOMEN WITH DIABETES WHO ARE IN-PATIENTS IN THE ROYAL INFIRMARY
MANAGEMENT OF PREGNANT WOMEN WITH DIABETES WHO ARE IN-PATIENTS IN THE ROYAL INFIRMARY Background Management is different in different groups of women with diabetes. Women with Type 1 Diabetes (previously
More informationGUIDELINE FOR THE MANAGEMENT OF HYPOGLYCAEMIA IN ADULTS WITH DIABETES MELLITUS
GUIDELINE FOR THE MANAGEMENT OF HYPOGLYCAEMIA IN ADULTS WITH DIABETES MELLITUS Guideline author Accountable Executive Lead Approving body Policy reference Diabetes Specialist Nurse Consultant Diabetologist
More informationObjectives. Why is blood glucose important? Hypoglycaemia. Hyperglycaemia. Acute Diabetes Emergencies (DKA,HONK)
Acute Diabetes Emergencies Ross Buchan, DSN North Glasgow September 2017 Objectives Why is blood glucose important? Hypoglycaemia Hyperglycaemia Acute Diabetes Emergencies (DKA,HONK) Importance of Blood
More informationHypoglyceamia and Exercise
Hypoglyceamia and Exercise Noreen Barker Diabetes Specialist Nurse May 2016 Hypoglyceamia What is a hypo? Why are we concerned? Signs and symptoms Treatments Causes Hypo unawareness Managing diabetes and
More informationIn-Hospital Management of Diabetes. Dr Benjamin Schiff Assistant Professor McGill University
In-Hospital Management of Diabetes Dr Benjamin Schiff Assistant Professor McGill University No conflict of interest to declare CLINICAL SCENARIO 62 y/o male with hx of DM 2, COPD, and HT is admitted with
More informationNew Treatments for Type 2 diabetes. Nandini Seevaratnam April 2016 Rushcliffe Patient Forum
New Treatments for Type 2 diabetes Nandini Seevaratnam April 2016 Rushcliffe Patient Forum Overview Growing population of Type 2 diabetes Basic science on what goes wrong Current treatments Why there is
More informationInpatient Diabetes and Hyperglycaemia. Philip Dyer Heart of England NHS Foundation Trust Birmingham
Inpatient Diabetes and Hyperglycaemia Philip Dyer Heart of England NHS Foundation Trust Birmingham A Case of Inpatient Diabetes 22.09.15 Mrs DE Ketosis-prone T2DM on bd Humulin-I, Metformin and Linagliptin
More informationPLEASE CHECK FULL SPECIFIC PRODUCT CHARACTERISTICS FOR MORE DETAILED AND CURRENT INFORMATION:
Metformin Standard tablets Modified-release tablets Metformin 1g sachets Metformin liquid 500mg/5ml (avoid use as expensive) < 2.00 5.32 for 56 tabs 500mg 13.16 for 60 sachets > 120 Ketoacidosis General
More informationPre-Dialysis Insulin Information for Patients with Type 2 Diabetes receiving haemodialysis
Pre-Dialysis Insulin Information for Patients with Type 2 Diabetes receiving haemodialysis Exceptional healthcare, personally delivered 2 This leaflet is for patients with Type 2 diabetes who require insulin
More informationA I Page 1 of 10. SIMPSON CENTRE FOR REPRODUCTIVE HEALTH ROYAL INFIRMARY of EDINBURGH. Clinical Protocol
SIMPSON CENTRE FOR REPRODUCTIVE HEALTH ROYAL INFIRMARY of EDINBURGH Clinical Protocol DIABETES IN PREGNANCY Diabetes; Management of GlycaemicControl in labour and in the antenatal period. Document Information
More informationInpatient Diabetes and Hyperglycaemia. Philip Dyer Heart of England NHS Foundation Trust Birmingham
Inpatient Diabetes and Hyperglycaemia Philip Dyer Heart of England NHS Foundation Trust Birmingham Outline of the Talk Definitions and the burden The impact and the cost A case The effects of hyperglycaemia
More informationGLP-1 Receptor Agonists and SGLT-2 Inhibitors. Debbie Hicks
GLP-1 Receptor Agonists and SGLT-2 Inhibitors Debbie Hicks Prescribing and Adverse Event reporting information is available at this meeting from the AstraZeneca representative The views expressed by the
More information3. Cardiovascular Disease?
Swiss recommendations 2016 Swiss Society of Endocrinology and Diabetology 1. Deficiency? Basal Premixed- Basal + GLP-1 RA (Xultophy ) or Basal Bolus 2. egfr < 30 ml/min? 3. Cardiovascular Disease? 4. Heart
More informationInsulin Initiation, titration & Insulin switch in the Primary Care-KISS
Insulin Initiation, titration & Insulin switch in the Primary Care-KISS Rotorua GP CME 9 June 2012 Dr Kingsley Nirmalaraj FRACP Endocrinologist, BOPDHB & Suite 9, Promed House, Tenth Ave, Tauranga Linda
More informationEXENATIDE (BYETTA ) PROTOCOL, 5mcg and 10mcg SC injection pre-filled pens
EXENATIDE (BYETTA ) PROTOCOL, 5mcg and 10mcg SC injection pre-filled pens This document should be read in conjunction with the current Summary of Product Characteristics http://www.medicines.org.uk 1.
More information